Recent Developments in the
Microbiome Diagnostic Market

Global
microbiome
diagnostic market is anticipated to grow at a CAGR of 11.4% during the forecast
period (2024-2031).  The market
growth is driven by the growing adoption of advanced technologies such as 16S rRNA
sequencing, shotgun metagenomics, and metatranscriptomics with increasing
demand for the human microbiome. Additionally, introducing novel solutions by
the market players in collaboration with academic researchers bolsters market
growth. Furthermore, the increasing
integration of machine learning and bioinformatics, and the increasing adoption
of multi-omics data for microbiome functional activities, are contributing
significantly towards the market growth.

Get Free Sample link @ https://www.omrglobal.com/request-sample/microbiome-diagnostic-market

The global microbiome diagnostic market is classified by product (reagents & kits, and instruments), by
technology (16s rRNA sequencing, shotgun metagenomics, metatranscriptomics, and
others), by end-users (hospitals, academic and research institutes and
biotechnology, and pharmaceutical companies), and by
geographies (North America, Europe, Asia-Pacific, and Rest of the World).

The major players in the
global microbiome diagnostic market Bio-Rad
Laboratories, Inc., Illumina, Inc., Merck KGaA, Takara Bio Inc., and Thermo
Fisher Scientific Inc., among others. The market players are contributing
significantly to the market growth, by the adoption of various business
strategies, such as collaborations, mergers and acquisitions, product portfolio
diversification, and more.

Full report of Microbiome
Diagnostic Market available @ https://www.omrglobal.com/industry-reports/microbiome-diagnostic-market

Recent Developments

·       
In October 2024, Genefitletics launched India's first microbiome-driven model to predict
cardiovascular diseases based on gut and oral microbiome gene expression. VASCOMATH is a predictive human
biology model that enables the prediction and early detection of chronic
diseases and provides interventions that can eliminate molecules involved in
disease or infection using nutrition as medicine so that diseases do not even
develop.

·       
In December 2023, The Dark Intelligence Group,
Inc., conducted a study about the latest developments in the microbiome
market in Asia. It highlighted the (then) recently launched ORAHYG microbiome diagnostic product by  Sushant Kumar Ventures Pvt. Ltd,
(Genefitletics). It is the first at-home oral microbiome functional activity
test available in Asia. The product can decode the root causes of,
gingivitis, dental cavities, bad breath, and gum disease. Additionally, it is
useful for the early detection development of, Type 2 diabetes, dementia,
arthritis, cardiovascular disease, and cancer.

·       
In January 2023, Genetic Analysis AS (GA) entered a Tech Transfer
Agreement with Microbiome Research Pvt. Ltd. (MRPL). MRPL will launch
a test service portfolio based on the GA-map® Dysbiosis Test, under the
partnership. The product will be the first CE-IVD-marked standardized gut
microbiome test on the Indian market. It will also target clinical research
customers and medical customers. 

·       
 In June 2022, Genetic
Analysis and Servatus entered into a strategic collaboration agreement to
develop new microbiome diagnostic and therapeutic solutions. The first stage
agreement involves the establishment of a ‘GA-map® Flagship Lab’ fully operational for microbiome analysis in
Servatus’ Queensland manufacturing facility. Additionally, the partnership will
utilize HumGut,
the human gut genome collection, and the GA biobank with data from global healthy and diseased
populations. 

·       
In February 2022, Genetic
Analysis AS launched the microbiome test on a new technology platform GA-map®
Dysbiosis Test kit commercially on the Luminex MAGPIX® system. The MAGPIX®
instrument enables up to 50 plex using MagPlex® Microspheres.

Reasons to Buying From
us -



1. We cover more than 15 major industries, further segmented into more than 90
sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For More Customized
Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/microbiome-diagnostic-market

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.